![Johannes Holzmeister](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Johannes Holzmeister
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Cardiorentis AG
![]() Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland.
5
| Private Company | Pharmaceuticals: Major | 5 |
DiNAQOR AG
![]() DiNAQOR AG BiotechnologyHealth Technology DiNAQOR AG is a Swiss genetic medicine platform company that focuses on developing innovative solutions for patients with severe, inherited forms of heart disease. The private company is based in Pfäffikon, Switzerland, and has additional presence in Massachusetts and other locations. The company's lead preclinical program, DINA-001, is aimed at treating mybpc3-linked cardiomyopathy. Founded in 2019, the CEO of DiNAQOR is Johannes Holzmeister.
4
| Private Company | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Johannes Holzmeister via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Maxygen, Inc.
![]() Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Director/Board Member | |
FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
NewAmsterdam Pharma Holding BV
![]() NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Director/Board Member | |
NewAmsterdam Pharma BV
![]() NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Recardia Therapeutics, Inc. | Director/Board Member | ||
ENTERPRISE 4.0 TECHNOLOGY ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
Merck Serono SA
![]() Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Doctorate Degree | |
Seqens SAS
![]() Seqens SAS Pharmaceuticals: MajorHealth Technology Seqens SASU engages in pharmaceutical and healthcare industries. The company was founded on April 2, 2003 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member | |
Sanofi-Aventis Pharmaceuticals | Corporate Officer/Principal | ||
The Heart Care Group
![]() The Heart Care Group Medical/Nursing ServicesHealth Services The Heart Care Group is an outpatient cardiac care practice that prioritizes wellbeing and preventative care. The American company offers a new take on cardiac wellness. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
BIOPLUS ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
Cardiac Rhythm Management
![]() Cardiac Rhythm Management Medical SpecialtiesHealth Technology Part of Japan Lifeline Co., Ltd., Cardiac Rhythm Management is a company that manufactures implantable devices to treat arrhythmias. The company is based in Sylmar, CA. | Medical Specialties | Corporate Officer/Principal | |
Emory University | College/University | Graduate Degree | |
Philadelphia College of Osteopathic Medicine | College/University | Corporate Officer/Principal | |
Hershey Medical Center | College/University | Corporate Officer/Principal | |
UNIQURE N.V. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
SwanBio Therapeutics, Inc.
![]() SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
CADRENAL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
University of Zurich | College/University | Graduate Degree | |
University of St. Gallen | College/University | Graduate Degree | |
EPIPHANY TECHNOLOGY ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
Revitope Oncology, Inc.
![]() Revitope Oncology, Inc. Hospital/Nursing ManagementHealth Services Revitope Oncology, Inc. develops a programmable antibody circuit pipeline in particular redirecting T cells to tumors. The company was founded by Andrew Allen and Mark Cobbold and is headquartered in Cambridge, MA. | Hospital/Nursing Management | Director/Board Member | |
Rochester Christian University | College/University | Director/Board Member | |
Asset Management Ventures LLC
![]() Asset Management Ventures LLC Investment ManagersFinance Asset Management Ventures LLC (AMV) is a venture capital subsidiary of Asset Management Co. founded in 1965 by Franklin Pitcher Johnson. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
VantagePoint Management, Inc.
![]() VantagePoint Management, Inc. Investment ManagersFinance VantagePoint Management, Inc. (VantagePoint) is a venture capital firm founded in 1996 by Alan Edward Salzman, James D. Marver. The firm is headquartered in Santa Barbara, California with additional office in Beijing, China. | Investment Managers | Private Equity Analyst | |
Synecor LLC
![]() Synecor LLC Investment ManagersFinance Synecor LLC (Synecor) is a venture capital firm founded in 2000 by Richard S. Stack, William N. Starling, and Judith L. Swain. The firm is headquartered in Chapel Hill, North Carolina. | Investment Managers | Corporate Officer/Principal | |
Washington University in St. Louis | College/University | Corporate Officer/Principal | |
CYMABAY THERAPEUTICS, INC. | Biotechnology | Chairman | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Jewish Hospital
![]() Jewish Hospital Hospital/Nursing ManagementHealth Services Part of Community Health Systems, Inc., Jewish Hospital is a hospital. The company is based in Cincinnati, OH. Jewish Hospital was acquired by Mercy Health Partners, Inc. (Pennsylvania), a NPO of Community Health Systems, Inc. from Jewish Foundation of Cincinnati on March 01, 2010 for $180 million. | Hospital/Nursing Management | Corporate Officer/Principal | |
Teon Therapeutics, Inc.
![]() Teon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Teon Therapeutics, Inc. operates as a pharmaceutical company. It focuses on cancer immunotherapy. The company was founded by Yao Lina, Fan Peidong, Elfaith Elzein, and Liiu Jiwen in March 2018 and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal | |
Institute for Systems Biology
![]() Institute for Systems Biology Miscellaneous Commercial ServicesCommercial Services Institute for Systems Biology operates as a nonprofit biomedical research organization. It develops a systems approach to characterize, predict, and manipulate state transitions in biological system. The company was founded by Leroy E. Hood, Ruedi Aebersold and Alan Aderem in 2000 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Chairman | |
Maverix Biomics, Inc.
![]() Maverix Biomics, Inc. Miscellaneous Commercial ServicesCommercial Services Maverix Biomics, Inc. provides cloud-based platform to manage, analyze and visualize genomic data. It also builds communities of discovery and place its data in context with the latest public data from the full spectrum of life, including human, plant, animal or microbial organisms. The company was founded by David Mandelkern, Todd Michael Johnson Lowe and Patricia Pak Lee Chan in 2010 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Harvard Medical School | College/University | Doctorate Degree | |
Cardiogen Sciences, Inc.
![]() Cardiogen Sciences, Inc. Pharmaceuticals: GenericHealth Technology Cardiogen Sciences, Inc. is a biotechnology company that develops and offers gene therapy solutions for orphan-inherited arrhythmogenic diseases. The company was founded by Louis G. Lange in 2014 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Generic | Founder | |
AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
InCarda Therapeutics, Inc.
![]() InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
Gladstone Foundation (CA) | Director/Board Member | ||
STEALTH BIOTHERAPEUTICS CORP | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 42 |
Nederland | 5 |
Zwitserland | 4 |
Duitsland | 2 |
Frankrijk | 2 |
Sectoraal
Health Technology | 21 |
Consumer Services | 12 |
Finance | 7 |
Commercial Services | 6 |
Health Services | 6 |
Operationeel
Director/Board Member | 30 |
Corporate Officer/Principal | 13 |
Independent Dir/Board Member | 11 |
Chief Tech/Sci/R&D Officer | 8 |
Chairman | 6 |
Sterkste connecties
- Beurs
- Insiders
- Johannes Holzmeister
- Bedrijfsconnecties